Recital 11, Regulation (EU) 2020/1163

In forcesince 6 Aug 2020

Following the receipt of the Authority’s scientific opinion, the Commission requested the applicant to further clarify the justification provided with regard to their proprietary data from Annex I (Raw materials and processing aids), Annex II (Certificates of Analysis and batch data) and Annex III (Stability reports) as regards vitamin D2 mushroom powder, and to clarify their claim to an exclusive right of reference to these reports and studies, as referred to in points (a) and (b) of Article 26(2) of Regulation (EU) 2015/2283.